Scarica l'app Stockscreener
4.105
10.95%
-0.505
Aquestive Therapeutics Inc Azioni (AQST) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
4.34%
13.82
|
14.45 | 13.02 | 12.81 | 10.00 |
| Cost Of Revenue |
15.80%
4.017
|
3.469 | 5.836 | 4.506 | 4.561 |
Selling, General, and Administrative
|
28.11%
14.06
|
10.98 | - | - | - |
| Costs And Expenses |
18.19%
22.04
|
18.65 | 41.85 | 24.29 | 21.37 |
| Depreciation and Amortization |
20.35%
0.136
|
0.113 | 0.13 | 0.139 | 0.14 |
| Operating Income/Loss |
95.60%
-8.223
|
-4.204 | -28.84 | -11.48 | -11.37 |
| Income/Loss From Continuing Operations Before Tax |
183.78%
-22.86
|
-8.057 | -31.86 | -15.45 | -13.55 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Net Income/Loss |
183.78%
-22.86
|
-8.057 | -31.86 | -15.45 | -13.55 |
| Basic Average Shares |
1.94%
124.99
|
122.61 | 5.0686 | 110.58 | 99.33 |
| Diluted Average Shares |
1.94%
124.99
|
122.61 | 5.0686 | 110.58 | 99.33 |
| Basic Earnings Per Share |
157.14%
-0.18
|
-0.07 | -0.27 | -0.14 | -0.14 |
| Diluted Earnings Per Share |
157.14%
-0.18
|
-0.07 | -0.27 | -0.14 | -0.14 |
0.70%
4.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):